PureTech Health Statistics
Share Statistics
PureTech Health has 24.02M
shares outstanding. The number of shares has increased by 8.48%
in one year.
| Shares Outstanding | 24.02M |
| Shares Change (YoY) | 8.48% |
| Shares Change (QoQ) | 0.32% |
| Owned by Institutions (%) | 0.14% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 8,712 |
| FTD / Avg. Volume | 179.08% |
Short Selling Information
The latest short interest is 10.35K, so 0.04% of the outstanding
shares have been sold short.
| Short Interest | 10.35K |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.06% |
| Short Ratio (days to cover) | 4.34 |
Valuation Ratios
The PE ratio is 9.3 and the forward
PE ratio is -2.63.
PureTech Health's PEG ratio is
-0.09.
| PE Ratio | 9.3 |
| Forward PE | -2.63 |
| PS Ratio | 115.36 |
| Forward PS | 0.8 |
| PB Ratio | 1.2 |
| P/FCF Ratio | -3.7 |
| PEG Ratio | -0.09 |
Financial Ratio HistoryEnterprise Valuation
PureTech Health has an Enterprise Value (EV) of 4.72B.
| EV / Sales | 1093.77 |
| EV / EBITDA | 126.25 |
| EV / EBIT | -35.12 |
| EV / FCF | -35.12 |
Financial Position
The company has a current ratio of 9.33,
with a Debt / Equity ratio of 0.05.
| Current Ratio | 9.33 |
| Quick Ratio | 9.33 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.6 |
| Debt / FCF | -0.17 |
| Interest Coverage | -13.56 |
Financial Efficiency
Return on Equity is 12.9% and Return on Invested Capital is -27.95%.
| Return on Equity | 12.9% |
| Return on Assets | 8.88% |
| Return on Invested Capital | -27.95% |
| Revenue Per Employee | $53,937.5 |
| Profits Per Employee | $668,875 |
| Employee Count | 80 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4.01M |
| Effective Tax Rate | -16.86% |
Stock Price Statistics
The stock price has increased by -41.35% in the
last 52 weeks. The beta is 0.87, so PureTech Health's
price volatility has been higher than the market average.
| Beta | 0.87 |
| 52-Week Price Change | -41.35% |
| 50-Day Moving Average | 17.27 |
| 200-Day Moving Average | 19.61 |
| Relative Strength Index (RSI) | 44.92 |
| Average Volume (20 Days) | 4,865 |
Income Statement
In the last 12 months, PureTech Health had revenue of 4.32M
and earned 53.51M
in profits. Earnings per share was 2.
| Revenue | 4.32M |
| Gross Profit | 4.32M |
| Operating Income | -136.09M |
| Net Income | 53.51M |
| EBITDA | 37.38M |
| EBIT | 33.81M |
| Earnings Per Share (EPS) | 2 |
Full Income StatementBalance Sheet
The company has 280.64M in cash and 22.36M in
debt, giving a net cash position of 258.28M.
| Cash & Cash Equivalents | 280.64M |
| Total Debt | 22.36M |
| Net Cash | 258.28M |
| Retained Earnings | 32.49M |
| Total Assets | 602.63M |
| Working Capital | 344.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -134.37M
and capital expenditures -11K, giving a free cash flow of -134.38M.
| Operating Cash Flow | -134.37M |
| Capital Expenditures | -11K |
| Free Cash Flow | -134.38M |
| FCF Per Share | -0.5 |
Full Cash Flow StatementMargins
Gross margin is 100%, with operating and profit margins of -3154% and 1240.09%.
| Gross Margin | 100% |
| Operating Margin | -3154% |
| Pretax Margin | 550.96% |
| Profit Margin | 1240.09% |
| EBITDA Margin | 866.33% |
| EBIT Margin | -3154% |
| FCF Margin | -3114.25% |
